MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
2. Industry_Business Architects & Consolidators
Industry: By Region (Globally)
Industry: U.S.(United States)
Industry: MidWest
*Industry: Ohio
Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) , formerly Neoprobe (Amex:NEOP)
Organization & Developments: Navidea Biopharmaceuticals
Parents
Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) , formerly Neoprobe (Amex:NEOP)
Children
2010: Neoprobe, FDA work to map plan for cancer-targeting agent (2010)
2011: Neoprobe unveils new name: Navidea Biopharmaceuticals (2011)
2020: Navidea Biopharmaceuticals: Too Many Risks Involved
425 Metro Place North, Suite 300
Neoprobe is a world leader in gamma detection technology and the only gamma detection company working to optimize both radiotracers and gamma detection hardware.
Primary area of focus is in improving cancer surgery outcomes by using our market-leading gamma detection devices in combination with radiopharmaceutical agents also referred to as “tracing” or “targeting” agents.
Radiopharmaceutical developer
Jumps
Finance & Acquisitions: Navidea Biopharmaceuticals
Key People: Navidea Biopharmaceuticals